Table 2 Percentage of the multidrug-resistant P. aeruginosa isolates that were resistant, non-resistant, sensitive to imipenem, meropenem and doripenem in the presence and absence of 20 mg/L rifampicin
Monotherapy | Combinations with RIF | |||||
|---|---|---|---|---|---|---|
IMP | MEM | DOR | IMP | MEM | DOR | |
(a) P. aeruginosa isolates without the carbapenemase (bla VIM) gene (65 isolates) | ||||||
Resistanta | 100 % (65/65) | 95.38 % (62/65) | 86.15 % (56/65) | 13.85 % (9/65) | 43.08 % (28/65) | 15.38 % (10/65) |
Non-resistantb | 0 % (0/65) | 4.62 % (3/65) | 13.85 % (9/65) | 86.15 % (56/65) | 56.92 % (37/65) | 84.62 % (55/65) |
Sensitivec | 0 % (0/65) | 0 % (0/65) | 1.54 % (1/65) | 73.85 % (48/65) | 47.69 % (31/65) | 47.69 % (31/65) |
(b) P. aeruginosa isolates with the carbapenemase (bla VIM) gene (6 isolates) | ||||||
Resistanta | 100 % (6/6) | 100 % (6/6) | 100 % (6/6) | 83.33 % (5/6) | 83.33 % (5/6) | 66.67 % (4/6) |
Non-resistantb | 0 % (0/6) | 0 % (0/6) | 0 % (0/6) | 16.67 % (1/6) | 16.67 % (1/6) | 33.33 % (2/6) |
Sensitivec | 0 % (0/6) | 0 % (0/6) | 0 % (0/6) | 0 % (0/6) | 0 % (0/6) | 0 % (0/6) |